🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1/2, open-label, multicenter study to determine the efficac...
Status
Active Not Recruiting
Location
Local Institution - 0006
Start Date
2017-11-27
Trial ID
NCT03331198
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
Current treatments for relapsed/refractory hematopoietic malignancies such ...
Status
Unknown
Location
Multiple Locations
Start Date
2021-03
Trial ID
NCT04767308
Treatments Being Tested
TAC01-HER2 is a novel cell therapy that consists of genetically engineered ...
Status
Terminated
Location
Lurie Cancer Center - Northwestern University
Start Date
2021-04-19
Trial ID
NCT04727151
Treatments Being Tested
This phase I/II trial investigates the side effects of genetically engineer...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-07-19
Trial ID
NCT04639245
This study is to investigate the safety and efficacy on TIL engineered with...
Status
Completed
Location
Shanghai Tenth People's Hospital
Start Date
2022-03-10
Trial ID
NCT05468307
Treatments Being Tested
This study is an open exploratory clinical study to evaluate the safety, to...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-08
Trial ID
NCT05971576
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficiency of autol...
Status
Active Not Recruiting
Location
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Start Date
2020-07-27
Trial ID
NCT04499573
Treatments Being Tested
This study is to investigate the safety and efficacy of tumor infiltrating ...
Status
Recruiting
Location
Tongren Hospital Shanghai Jiao Tong University School Of Medicine.
Start Date
2021-04-22
Trial ID
NCT04967833
Treatments Being Tested
This phase II trial studies how well the addition of nemtabrutinib to lisoc...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-09-01
Trial ID
NCT07194980
Treatments Being Tested